October 20, 2014 |
Next month, Thomas G. Frazier will sit down with colleagues at Bryn Mawr Hospital's Comprehensive Breast Center and unseal the results of a blind study for Dune Medical's MarginProbe. The four-month, 30-patient study is the second conducted at Bryn Mawr on the new diagnostic tool designed to help breast cancer surgeons determine - within minutes - whether they have removed all the malignant tissue during a lumpectomy and reduced the need for later surgery. If the second study is positive, the device could become a key tool for breast cancer surgeons at Bryn Mawr and elsewhere.
September 30, 2002 |
The people who wanted to call attention to the hopes and tragedies of breast cancer needed a big billboard for their message - the biggest they could find. Hey, how about the skyline itself? Sure. Get the city, the Port Authority, business firms to light the exteriors of their buildings and landmarks pink, the offical ribbon color in the fight against breast cancer. And so, starting tomorrow at dusk, and continuing through October, Philly's skyline is going to glow pink as part of the breast cancer awareness campaign of KYW-TV and the Philadelphia affiliate of the Susan G. Komen Breast Cancer Foundation.
November 25, 2010 |
One year ago, Shelley Dodt received a thrilling e-mail from her University of Pennsylvania breast surgeon: Dodt, now 56, of Palm City, Fla., had received Brian J. Czerniecki's experimental vaccine to treat her early-stage breast cancer, called DCIS, before having surgery to remove the cancer. The pathologist who examined the excised tissue under a microscope could not find any malignant cells. Revved by the vaccine, her immune system had wiped out the cancer. Few other patients have responded so completely to the vaccine, and no one can yet say whether the protective effect will decline over time.
January 25, 1991 |
One in nine American women can now expect to develop breast cancer at some time in their lives, continuing a steady increase in the risk women face, according to the American Cancer Society. The society has been saying since 1987 that the average American woman faced a 1-in-10 chance of developing breast cancer. It revised the risk upward yesterday to reflect an increase in the reported incidence of breast cancer in the 1980s, due in part to better detection methods and the fact that women are living longer.
October 6, 1991 |
Thom Bernitsky and Lenore Urban, husband and wife, feel free to speak openly to each other. So when his wife was diagnosed as having breast cancer in 1989, Bernitsky said, they naturally talked about their feelings of devastation and confusion. There were questions that needed to be answered - the "whys," as Bernitsky put it - and depression that needed to be faced and dealt with. They sought counseling and went to sessions together. Bernitsky went to a partners group for husbands of women with breast cancer at Fox Chase Cancer Center in Northeast Philadelphia.
December 7, 2011 |
SAN ANTONIO - New research casts doubt on a popular treatment for breast cancer: a week of radiation to part of the breast instead of longer treatment to all of it. Women who were given partial radiation were twice as likely to need their breasts removed later because the cancer came back, doctors found. The treatment uses radioactive pellets briefly placed in the breast instead of radiation beamed from a machine. At least 13 percent of older patients in the United States get this now, and it is popular with working women.
January 29, 2001 |
Two years after studies showed no survival benefit for women who underwent bone marrow transplants for advanced breast cancer, the arduous treatment has become so unpopular that researchers cannot find enough patients for studies aimed at improving it and showing a benefit. What's more, some health insurers are refusing coverage for the few breast cancer patients who do want to participate in studies of new bone marrow transplant procedures. The treatment typically costs $60,000 to $100,000.
March 14, 2007 |
In a drug industry sometimes accused of putting profits before patients, GlaxoSmithKline P.L.C.'s announcement of a new anticancer drug yesterday stood out: Patients cheered and investors shrugged. "It's incredible news!" Lizann DeAngelis, 43, a Downingtown woman with metastatic cancer, said after hearing that federal regulators had approved the breakthrough drug she has tried in vain to get. "This is another weapon in my arsenal. " The long-sought drug, Tykerb, developed by London-based GlaxoSmithKline partly at its facilities in Montgomery County, got a dimmer reaction from equity analysts.
May 18, 2005 |
AUSTRALIAN pop star Kylie Minogue has been diagnosed with breast cancer. She has canceled her tour of Australia and will undergo immediate treatment. Known in the United States for the songs "Can't Get You Out of My Head," "Slow" and her album, "Fever," Minogue is a huge star overseas - a tabloid babe known for sexy clothing and a bum more famous than that of Jennifer Lopez. The 36-year-old performer's diagnosis was confirmed this week during a visit with her family in Melbourne.
July 13, 1991 |
Purple Breasts, which opened Thursday night as part of the New Hope Performing Arts Festival, is the second area theater piece in as many days to search for art among the grim facts of illness and death. As with the first such piece, the AIDS revue C'est la Guerre at Philadelphia's Wilma Theater, the search goes largely unrewarded. A one-act play about breast cancer and its emotional effects, Purple Breasts was collaboratively developed in March 1989 at San Jose City College in California by a cast of four and director Daryl Lindstrom, who was suffering from metastatic breast cancer at the time.